Endocrine Determinants of Renal Function in Patients With Hypoparathyroidism
NCT06449729 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46
Last updated 2024-06-10
Summary
Endocrine determinants of renal function in patients with hypoparathyroidism on conventional treatment: a cross-sectional study (ENDORSE)
Conditions
- Hypoparathyroidism
Interventions
- DIAGNOSTIC_TEST
-
Blood sample and urine collection
Blood sample and urine collection as per clinical practice
Sponsors & Collaborators
-
IRCCS San Raffaele
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-28
- Primary Completion
- 2023-04-28
- Completion
- 2023-04-28
Countries
- Italy
Study Locations
More Related Trials
-
DePTH: De-emphasize PTH
NCT06288451 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Parathyroid Hyperplasia in Patients With Chronic Kidney Disease.
NCT03182517 ·Status: UNKNOWN
-
The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid
NCT02056730 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients
NCT03082742 ·Status: UNKNOWN ·Phase: NA
-
Pyrophosphate and Arterial Calcification in Chronic Kidney Disease
NCT04950439 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.
NCT01939977 ·Status: COMPLETED ·Phase: PHASE4
-
Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
NCT00299572 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Active Vitamin D and Etelcalcetide on Human Osteoclasts in Patients With Chronic Kidney Disease
NCT03527511 ·Status: COMPLETED
-
Ergocalciferol in Chronic Kidney Disease
NCT00411294 ·Status: COMPLETED
-
Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease
NCT00995163 ·Status: COMPLETED
-
FGF-23 and PTH in Hemodialysis Patients
NCT04350944 ·Status: COMPLETED
-
Evaluation of Colecalciferol Substitution in Dialysis Patients
NCT00397475 ·Status: COMPLETED ·Phase: NA
-
A Single Arm Study Comparing ACC Supplement to CCS in Management of Hypoparathyroidism
NCT06288490 ·Status: TERMINATED ·Phase: NA
-
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
NCT00446329 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of Secondary Hyperparathyroidism in the Uremic Patient
NCT00469599 ·Status: TERMINATED ·Phase: NA
-
Registry for Hypoparathyroidism Wuerzburg
NCT05585593 ·Status: RECRUITING
-
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
NCT00261950 ·Status: COMPLETED ·Phase: PHASE2
-
Optimal Anemia Treatment in End Stage Renal Disease (ERSD)
NCT02273570 ·Status: UNKNOWN ·Phase: NA
-
Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyroid Hormone in Chronic Kidney Disease
NCT01071070 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Regulation of Parathyroid Hormone by Dietary Phosphate
NCT00037193 ·Status: COMPLETED
-
Efficacy of Calcium Citrate Versus Calcium Carbonate for the Management of Chronic Hypoparathyroidism
NCT03425747 ·Status: COMPLETED ·Phase: PHASE4
-
Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
NCT01725113 ·Status: TERMINATED ·Phase: PHASE4
-
Assessing Bone Calcium Content in Children With Kidney Disease Treated With Two Different Medicines
NCT04120922 ·Status: UNKNOWN ·Phase: NA
-
Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands
NCT01273597 ·Status: COMPLETED
-
Sub-total Parathyroidectomy Reduces Vascular Calcification in Haemodialysis Patients
NCT01140490 ·Status: UNKNOWN ·Phase: NA